Recombinant spider silk particles for controlled delivery of protein drugs

Biomaterials

Volumn 33, Issue 5, 2012, Pages 1554-1562

  Hofer, Markus ^a   Winter, Gerhard ^a   Myschik, Julia ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomimetic material; Drug delivery; Lysozyme; Nanoparticle; Spider silk

Indexed keywords

CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED DELIVERY; DRUG CARRIER SYSTEMS; DRUG DELIVERY SYSTEM; HIGH LOADINGS; LONG TERM STABILITY; LOW MOLECULAR WEIGHT DRUGS; LYSOZYME; MACROMOLECULAR DRUGS; MATRIX; MODEL PROTEINS; PARTICLE DEGRADATION; PROTEIN DRUGS; RECOMBINANT SPIDER SILK PROTEINS; SPIDER SILKS; THERAPEUTIC PROTEIN;

BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMIMETIC MATERIALS; BIOMIMETICS; CONFOCAL MICROSCOPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; ENZYMES; IONIC STRENGTH; NANOPARTICLES; PROTEINS; SILK; SUGAR (SUCROSE);

AGGLOMERATION;

CARRIER PROTEIN; DRUG CARRIER; LYSOZYME; MANNITOL; PROTEIN EADF4(C16); SUCROSE; TREHALOSE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CELL AGGREGATION; COLLOID; CONFOCAL LASER MICROSCOPY; DEGRADATION; DISPERSION; DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; FREEZE DRYING; IONIC STRENGTH; PARTICLE SIZE; PH MEASUREMENT; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; COLLOIDS; DELAYED-ACTION PREPARATIONS; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; MACROMOLECULAR SUBSTANCES; MICROSCOPY, CONFOCAL; MURAMIDASE; OSMOLAR CONCENTRATION; PARTICLE SIZE; RECOMBINANT PROTEINS; SILK; SPIDERS; STATIC ELECTRICITY; SUSPENSIONS;

ARANEAE;

EID: 83355166780     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.053     Document Type: Article

References (37)

1. Edlund U., Albertsson A.C. Degradable polymer microspheres for controlled drug delivery. Degradable aliphatic polyesters 2002, 67-112. Springer, Berlin. A.C. Albertsson (Ed.).
2. Gombotz W.R., Pettit D.K. Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 1995, 6:332-351.
3. Wenk E., Merkle H.P., Meinel L. Silk fibroin as a vehicle for drug delivery applications. J Control Release 2011, 150:128-141.
4. Sinha V.R., Trehan A. Biodegradable microspheres for protein delivery. J Control Release 2003, 90:261-280.
5. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55:329-347.
6. Estey T., Kang J., Schwendeman S.P., Carpenter J.F. BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci 2006, 95:1626-1639.
7. van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000, 17:1159-1167.
8. Brunner A., Mäder K., Göpferich A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm Res 1999, 16:847-853.
9. Xu Y., Du Y., Huang R., Gao L. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 2003, 24:5015-5022.
10. Xu Y., Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003, 250:215-226.
11. Gan Q., Wang T. Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007, 59:24-34.
12. Amidi M., Romeijn S.G., Borchard G., Junginger H.E., Hennink W.E., Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 2006, 111:107-116.
13. Prokop A., Kozlov E., Newman G.W., Newman M.J. Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application. Biotechnol Bioeng 2002, 78:459-466.
14. Coester C.J., Langer K., Von Briesen H., Kreuter J. Gelatin nanoparticles by two step desolvation - a new preparation method, surface modifications and cell uptake. J Microencapsul 2000, 17:187-193.
15. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
16. Panilaitis B., Altman G.H., Chen J., Jin H.-J., Karageorgiou V., Kaplan D.L. Macrophage responses to silk. Biomaterials 2003, 24:3079-3085.
17. Vollrath F., Barth P., Basedow A., Engstrom W., List H. Local tolerance to spider silks and protein polymers in vivo. In Vivo 2002, 16:229-234.
18. Spiess K., Lammel A., Scheibel T. Recombinant spider silk proteins for applications in biomaterials. Macromol Biosci 2010, 10:998-1007.
19. Humenik M., Smith A.M., Scheibel T. Recombinant spider silks - biopolymers with potential for future applications. Polymers 2011, 3:640-661.
20. Wilz A., Pritchard E.M., Li T., Lan J.-Q., Kaplan D.L., Boison D. Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials 2008, 29:3609-3616.
21. Wang X., Wenk E., Matsumoto A., Meinel L., Li C., Kaplan D.L. Silk microspheres for encapsulation and controlled release. J Control Release 2007, 117:360-370.
22. Wang X., Wenk E., Zhang X., Meinel L., Vunjak-Novakovic G., Kaplan D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 2009, 134:81-90.
23. Wang X., Yucel T., Lu Q., Hu X., Kaplan D.L. Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials 2010, 31:1025-1035.
24. Wenk E., Wandrey A.J., Merkle H.P., Meinel L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 2008, 132:26-34.
25. Zhang Y.-Q., Shen W.-D., Xiang R.-L., Zhuge L.-J., Gao W.-J., Wang W.-B. Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization. J Nanopart Res 2007, 9:885-900.
26. Scheibel T. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact 2004, 3:14.
27. Huemmerich D., Helsen C.W., Quedzuweit S., Oschmann J., Rudolph R., Scheibel T. Primary structure elements of spider dragline silks and their contribution to protein solubility. Biochemistry 2004, 43:13604-13612.
28. Slotta U., Rammensee S., Gorb S., Scheibel T. An engineered spider silk protein forms microspheres. Angew Chem Int Ed Engl 2008, 47:4592-4594.
29. Rammensee S., Slotta U., Scheibel T., Bausch A.R. Assembly mechanism of recombinant spider silk proteins. P Natl Acad Sci USA 2008, 105:6590-6595.
30. Lammel A., Schwab M., Slotta U., Winter G., Scheibel T. Processing conditions for the formation of spider silk microspheres. Chem Sus Chem 2008, 1:413-416.
31. Lammel A., Schwab M., Hofer M., Winter G., Scheibel T. Recombinant spider silk particles as drug delivery vehicles. Biomaterials 2011, 32:2233-2240.
32. Van Tomme S.R., De Geest B.G., Braeckmans K., De Smedt S.C., Siepmann F., Siepmann J., et al. Mobility of model proteins in hydrogels composed of oppositely charged dextran microspheres studied by protein release and fluorescence recovery after photobleaching. J Control Release 2005, 110:67-78.
33. Hermanson K.D., Harasim M.B., Scheibel T., Bausch A.R. Permeability of silk microcapsules made by the interfacial adsorption of protein. Phys Chem Chem Phys 2007, 9:6442-6446.
34. Abdelwahed W., Degobert G., Stainmesse S., Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006, 58:1688-1713.
35. Tang X., Pikal M. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004, 21:191-200.
36. Zillies J.C., Zwiorek K., Hoffmann F., Vollmar A., Anchordoquy T.J., Winter G., et al. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm 2008, 70:514-521.
37. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000, 203:1-60.